IRADIMED CORP

IRMDNASDAQ

🏆 #2017 by market capEarnings Nov 2US Equity

$88.94▼ $1.31 (−1.47%)

Market closed · at close

1h—

24h▼ 1.5%

7d▼ 3.3%

14d▼ 5.6%

30d▼ 8.5%

1y▲ 23.3%

🏦Market Cap

$1.14B

Small Cap

📈Revenue Growth (YoY)

+11.2%

Healthy

📊Gross Margin

75.9%

High

💵FCF Margin

28.4%

Strong

⚖️P/S Ratio

13.7x

Elevated

Otter Score

Weak

Trading Snapshot

Day Range: $88.08 – $89.46
52-Week Range: $67.84 – $107.90
Volume: $2.22B
Avg Volume: $2.86B
Shares Outstanding: 12.8M
Next Earnings: Sep 18, 2026

Fundamentals Snapshot

Annual Revenue: $84M
Last Q Revenue: $20M
P/E Ratio: 51.3
P/S Ratio: 13.7x
EPS (TTM): $1.79
Dividend Yield: 1.34%

Why Investors Own IRMD

✓High-growth profile — revenue up +25.3% YoY with expanding US Equity exposure.
✓Healthy economics — 50% gross margin and 8% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$84M▲ +31.1% YoY

Gross Margin (TTM)

50.0%▲ +4.0% YoY

Operating Income (TTM)

$16M▲ +31.1% YoY

Free Cash Flow (TTM)

$7M▲ +31.1% YoY

About IRADIMED CORP

IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.

🦦